Severe Hypertriglyceridemia (sHTG)
4 clinical trials · Condition
◉ Watch Severe Hypertriglyceridemia (sHTG)
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy Following Repeat-Dose of Evinacumab (Anti-ANGPTL3) in Patients With Severe Hypertriglyceridemia (sHTG) at Risk for Acute Pancreatitis (NCT03452228) | Regeneron Pharmaceuticals | 2018-06-07 |
Track Severe Hypertriglyceridemia (sHTG) automatically
Every clearance here is in the API, with alerts when new ones post.